Cargando…

Hypofractionated Radiation Therapy for Large Brain Metastases

Single fraction radiosurgery (SRS) treatment is an effective and recognized alternative to whole brain radiation for brain metastasis. However, SRS is not always possible, especially in tumors of a larger diameter where the administration of high dose in a single fraction is limited by the possibili...

Descripción completa

Detalles Bibliográficos
Autor principal:	Masucci, Giuseppina Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176274/ https://www.ncbi.nlm.nih.gov/pubmed/30333955 http://dx.doi.org/10.3389/fonc.2018.00379

Ejemplares similares

Use of Helical TomoTherapy for the Focal Hypofractionated Treatment of Limited Brain Metastases in the Initial and Recurrent Setting
por: Elson, Andrew, et al.
Publicado: (2015)

Hypofractionated Image-Guided Radiation Therapy With Simultaneous-Integrated Boost Technique for Limited Metastases: A Multi-Institutional Analysis
por: Jacobs, Corbin D., et al.
Publicado: (2019)

Significance of low-dose radiation distribution in development of radiation pneumonitis after helical-tomotherapy-based hypofractionated radiotherapy for pulmonary metastases
por: Jo, In-Young, et al.
Publicado: (2014)

Editorial: Effects of radiation therapies on brain metastases
por: Kotecha, Rupesh, et al.
Publicado: (2023)

Mild Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
por: Matsui, Toshiaki, et al.
Publicado: (2020)

Outcomes of Hypofractionated Stereotactic Radiotherapy for Small and Moderate-Sized Brain Metastases: A Single-Institution Analysis
por: Yan, Michael, et al.
Publicado: (2022)

Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients
por: Sayan, Mutlay, et al.
Publicado: (2019)

The Efficacy and Safety of Hypofractionated Radiation Therapy With Tomotherapy for Advanced or Recurrent Hepatocellular Carcinoma
por: Shen, Jie, et al.
Publicado: (2021)

The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial Lesions
por: Laine, Aaron Michael, et al.
Publicado: (2016)

Low Incidence of Fatigue after Hypofractionated Stereotactic Body Radiation Therapy for Localized Prostate Cancer
por: Dash, Chiranjeev, et al.
Publicado: (2012)

Hypofractionated electron-beam radiation therapy for keloids: retrospective study of 568 cases with 834 lesions
por: Shen, Jie, et al.
Publicado: (2015)

Regression of a Fungating Tumor After Hypofractionated Radiation Therapy in a Patient With Metastatic Breast Cancer
por: Quackenbush, Kevin, et al.
Publicado: (2017)

Variations in whole brain radiation therapy fractionation for brain metastases in Victoria
por: Chee, Lessandra Yan Shan, et al.
Publicado: (2022)

Cyberknife(®) hypofractionated stereotactic radiosurgery (CK-hSRS) as salvage treatment for brain metastases
por: Telentschak, Sergej, et al.
Publicado: (2021)

Radiation Therapy for Palliation of Sarcoma Metastases: A Unique and Uniform Hypofractionation Experience
por: Soyfer, Viacheslav, et al.
Publicado: (2010)

Management Strategies for Large Brain Metastases
por: Sarmey, Nehaw, et al.
Publicado: (2022)

Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer
por: Lara, Pedro C., et al.
Publicado: (2022)

Lung-heart toxicity in a randomized clinical trial of hypofractionated image guided radiation therapy for breast cancer
por: Van Parijs, Hilde, et al.
Publicado: (2023)

Hypofractionated Postmastectomy Radiation Therapy
por: Sayan, Mutlay, et al.
Publicado: (2020)

Diagnosis and Management of Radiation Necrosis in Patients With Brain Metastases
por: Vellayappan, Balamurugan, et al.
Publicado: (2018)

Survival Outcomes of Patients Treated with Hypofractionated Stereotactic Body Radiation Therapy for Parotid Gland Tumors: a Retrospective Analysis
por: Karam, Sana D., et al.
Publicado: (2012)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
por: Gutschenritter, Tyler, et al.
Publicado: (2020)

Radiation Plus Anti-PD-1 Therapy for NSCLC Brain Metastases: A Retrospective Study
por: Liao, Guixiang, et al.
Publicado: (2021)

A novel hydrogel orthotopic injection model in moderately hypofractionated radiation therapy for prostate cancer: Adaptive degradation and durable imaging
por: Yu, Hao, et al.
Publicado: (2023)

Adaptive radiation therapy strategies in the treatment of prostate cancer patients using hypofractionated VMAT
por: Siciarz, Pawel, et al.
Publicado: (2021)

Adaptive hypofractionated gamma knife radiosurgery in the acute management of brainstem metastases
por: Sinclair, Georges, et al.
Publicado: (2019)

Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2020)

Adaptive hypofractionated gamma knife radiosurgery in the acute management of large thymic carcinoma brain metastases
por: Sinclair, Georges, et al.
Publicado: (2017)

Predictors for Long-Term Survival Free from Whole Brain Radiation Therapy in Patients Treated with Radiosurgery for Limited Brain Metastases
por: Gorovets, Daniel, et al.
Publicado: (2015)

Cowpea Mosaic Virus Nanoparticle Enhancement of Hypofractionated Radiation in a B16 Murine Melanoma Model
por: Duval, Kayla E. A., et al.
Publicado: (2020)

Whole Brain Radiation Therapy Plus Focal Radiation Boost May Generate Better Survival Benefit for Brain Metastases From Non-small Cell Lung Cancer
por: Ni, Meng, et al.
Publicado: (2020)

Hypofractionated Radiotherapy in African Cancer Centers
por: Swanson, William, et al.
Publicado: (2021)

Stereotactic Radiation Therapy (SRT) for Brain Metastases of Multiple Primary Tumors: A Single Institution Retrospective Analysis
por: Gu, Lei, et al.
Publicado: (2019)

Whole Brain Radiation Therapy Plus Stereotactic Radiosurgery in the Treatment of Brain Metastases Leading to Improved Survival in Patients With Favorable Prognostic Factors
por: Khan, Muhammad, et al.
Publicado: (2019)

Investigation of the efficacy and safety of CyberKnife hypofractionated stereotactic radiotherapy for brainstem metastases using a new evaluation criterion: ‘symptomatic control’
por: Nakamura, Masaki, et al.
Publicado: (2017)

A dummy-run evaluation of postoperative hypofractionated intensity-modulated radiation therapy (POHIM-RT) trials for cervical cancer
por: Cho, Won Kyung, et al.
Publicado: (2020)

Magnetic Resonance Image-Guided Hypofractionated Ablative Radiation Therapy for Hepatocellular Carcinoma With Tumor Thrombus Extending to the Right Atrium
por: Dincer, Neris, et al.
Publicado: (2022)

Impact of Tyrosine Kinase Inhibitors (TKIs) Combined With Radiation Therapy for the Management of Brain Metastases From Renal Cell Carcinoma
por: Khan, Muhammad, et al.
Publicado: (2020)

Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases
por: Scouarnec, Cyrielle, et al.
Publicado: (2019)

Salvage Hypofractionated Radiotherapy in a Progressive Radiation-Induced Angiosarcoma: A Case Report
por: Bonzano, Elisabetta, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_amovtb3cismn5abi9hh8819256